Pharmacyclics Llc Drug Patent Portfolio

Pharmacyclics Llc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Pharmacyclics Llc News

Calcutta High Court overturns the Indian Patent Office's rejection of Pharmacyclics' application.

22 Oct, 2025

Calcutta High Court Overturns Refusal of Divisional Patent for Combination Drug

22 Sep, 2025

AbbVie strengthens its cancer drug portfolio through $21 billion acquisition of Pharmacyclics - Yahoo News UK

10 Jun, 2024

See More